Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study

BACKGROUND: The impact of nonalcoholic fatty liver disease (NAFLD) on overall survival (OS), treatment response and toxicity in patients with hepatocellular carcinoma (HCC) treated with sorafenib is unknown. We examined the impact of NAFLD on survival and toxicity in an international cohort of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Howell, Jessica, Samani, Amit, Mannan, Binish, Hajiev, Saur, Motedayen Aval, Leila, Abdelmalak, Rebecca, Tam, Vincent C., Bettinger, Dominik, Thimme, Robert, Taddei, Tamar H., Kaplan, David E., Seidensticker, Max, Sharma, Rohini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527996/
https://www.ncbi.nlm.nih.gov/pubmed/36199289
http://dx.doi.org/10.1177/17562848221100106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527996/
https://www.ncbi.nlm.nih.gov/pubmed/36199289
http://dx.doi.org/10.1177/17562848221100106

Ejemplares similares